Accenture, Merck, Amazon partner to advance drug innovation and research
Drug Discovery | News | 0 Comment | 18 Sep, 2018
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform de...Read more
Pfizer receives Breakthrough Therapy designation for inhibitor drug
Drug Discovery | News | 0 Comment | 06 Sep, 2018
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (...Read more
China approves first "Made in China" cancer drug
Drug Discovery | News | 0 Comment | 06 Sep, 2018
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the National Medical Products Administration of China (“NMPA”, f...Read more
BeiGene Announces Acceptance of its First NDA for Zanubrutinib
Drug Discovery | News | 0 Comment | 28 Aug, 2018
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the China Drug Administration (CDA) of a new drug application (NDA) fo...Read more
FDA approves first drug for neurotrophic keratitis
Drug Discovery | News | 0 Comment | 23 Aug, 2018
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear ...Read more
Strides Pharma receives USFDA nod for two key ANDAs
Drug Discovery | News | 0 Comment | 22 Aug, 2018
India's Strides Pharma has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received ANDA “acceptable for filing” corre...Read more
GIC receives govt funding for immuno-oncology project
Drug Discovery | News | 0 Comment | 22 Aug, 2018
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related...Read more
Roche's Alecensa receives 'priority review' designation from CNDA
Drug Discovery | News | 0 Comment | 21 Aug, 2018
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization for Alecensa (alectinib) as a monotherapy treatment for patients with a...Read more
HitGen collaborates with LG Chem
Drug Discovery | News | 0 Comment | 20 Aug, 2018
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more
Blueberry Therapeutics raises £10M funding to develop nanomedicines
Drug Discovery | News | 0 Comment | 16 Aug, 2018
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more
Multi- institutional alliance to develop anti-aging drugs
Drug Discovery | News | 0 Comment | 16 Aug, 2018
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more
FDA approves Amicus' Galafold for Fabry disease
Drug Discovery | News | 0 Comment | 13 Aug, 2018
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more
Pfizer's Innovative drug IBRANCE gets China approval
Drug Discovery | News | 0 Comment | 08 Aug, 2018
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more
DotBio successfully raises $2.3 M in seed financing
Drug Discovery | News | 0 Comment | 07 Aug, 2018
Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully rai...Read more
Medpacto inks deal with AstraZeneca
Drug Discovery | News | 0 Comment | 02 Aug, 2018
MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto’s vactosertib (TEW-7197), a small molecule, oral inhibitor of ...Read more
Pfizer's Herceptin biosimilar approved in Europe
Drug Discovery | News | 0 Comment | 31 Jul, 2018
Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cancer med Herceptin (trastuzumab). TRAZIMERA, a potential biosimilar to ...Read more
Nektar's back pain opioid gets approval for FDA review
Drug Discovery | News | 0 Comment | 30 Jul, 2018
Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more
Agios receives nod for ivosidenib
Drug Discovery | News | 0 Comment | 23 Jul, 2018
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more